electroCore Announces Full Year 2024 Financial Results
March 12, 2025 16:05 ET
|
electroCore, Inc.
Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCoreTM in the United States Department of Veteran...
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025
March 06, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial...
electroCore to Participate at Upcoming Investor Conferences
March 05, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
Spark Biomedical Partners With Air Force To Launch Trial Testing Innovative Solution to Motion Sickness and Spatial Disorientation
February 20, 2025 09:37 ET
|
Spark Biomedical
Dallas, TX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a global leader in wearable neurostimulation technology, announces an innovative study to explore the effectiveness of transcutaneous...
electroCore’s Truvaga™ Now Available on Amazon®
February 19, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its flagship wellness...
electroCore Expands Intellectual Property Portfolio
February 06, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received two patent...
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 04, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th...
electroCore Expands Intellectual Property Portfolio
January 07, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received five patent...
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
December 17, 2024 16:05 ET
|
electroCore, Inc.
The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at...
electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award
November 20, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness...